Welcome to our Corporate client solution
Your IP is registered with the company mentioned above and provides access to Life Science Sweden.
Lundbaserade Hansa Biopharma har tagit in 372,2 miljoner kronor i en riktad nyemission där flera amerikanska specialistinvesterare deltar.